These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3487559)

  • 1. Potassium para-aminobenzoate and liver function test findings.
    Zarafonetis CJ; Dabich L; DeVol EB; Rossi C; Skovronski JJ
    J Am Acad Dermatol; 1986 Jul; 15(1):144-9. PubMed ID: 3487559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver toxicity from potassium para-aminobenzoate.
    Kantor GR; Ratz JL
    J Am Acad Dermatol; 1985 Oct; 13(4):671-2. PubMed ID: 3878370
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hepatitis associated with treatment of Peyronie's disease with potassium para-aminobenzoate (Potaba).
    Roy J; Carrier S
    J Sex Med; 2008 Dec; 5(12):2967-9. PubMed ID: 18624965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver injury due to potassium para-aminobenzoate (Potaba)].
    Mesnil A; Lewden B; Dumortier J; Cuche M; Euvrard P; Dorez D; Vial T
    Gastroenterol Clin Biol; 2004 Dec; 28(12):1295-6. PubMed ID: 15671944
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary and update: cutaneous sensitivity to monoglyceryl para-aminobenzoate.
    Mathias CG
    Cleve Clin Q; 1983; 50(2):85-6. PubMed ID: 6605822
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Peyronie's disease with potassium para-aminobenzoate (potaba).
    ZARAFONETIS CJ; HORRAX TM
    J Urol; 1959 Jun; 81(6):770-2. PubMed ID: 13655401
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous sensitivity to monoglycerol para-aminobenzoate cross sensitization and bilateral eczematization. By George H. Curtis and P.F. Crawford.
    Cleve Clin Q; 1983; 50(2):77-83. PubMed ID: 6357550
    [No Abstract]   [Full Text] [Related]  

  • 8. Retrospective studies in scleroderma: effect of potassium para-aminobenzoate on survival.
    Zarafonetis CJ; Dabich L; Negri D; Skovronski JJ; DeVol EB; Wolfe R
    J Clin Epidemiol; 1988; 41(2):193-205. PubMed ID: 3257255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroa vacciniforme treated with potassium para-aminobenzoate.
    ZARAFONETIS CJ; CURTIS AC; SHAW JM
    J Invest Dermatol; 1953 Jul; 21(1):5-7. PubMed ID: 13069835
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross sensitization from para-aminobenzoate in sunburn preventives.
    GAUL LE
    Anesthesiology; 1955 Jul; 16(4):606-14. PubMed ID: 13238877
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of pemphigus with potassium para-aminobenzoate.
    ZARAFONETIS CJ; CURTIS AC; SHAW JM
    Am J Med Sci; 1956 Jan; 231(1):30-50. PubMed ID: 13275470
    [No Abstract]   [Full Text] [Related]  

  • 12. Rare Incidence of Acute Liver Injury with Potassium Para-Aminobenzoate Introduction.
    Al Attar L; Kilgore W
    Case Rep Gastroenterol; 2018; 12(2):230-233. PubMed ID: 29928188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of para-aminobenzoic acid (PABA) form and administration mode on PABA recovery in 24-hour urine collections.
    Sharma RS; Joy RC; Boushey CJ; Ferruzzi MG; Leonov AP; McCrory MA
    J Acad Nutr Diet; 2014 Mar; 114(3):457-463. PubMed ID: 24183994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Asthma therapy; p-aminobenzoate of potassium theophylline].
    SANNAZZARI P
    Arch Maragliano Patol Clin; 1951; 6(2):419-32. PubMed ID: 14857964
    [No Abstract]   [Full Text] [Related]  

  • 15. Retrospective studies in scleroderma: skin response to potassium para-aminobenzoate therapy.
    Zarafonetis CJ; Dabich L; Skovronski JJ; DeVol EB; Negri D; Yuan W; Wolfe R
    Clin Exp Rheumatol; 1988; 6(3):261-8. PubMed ID: 3180546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dangers of orally administered para-aminobenzoic acid.
    Worobec S; LaChine A
    JAMA; 1984 May; 251(18):2348. PubMed ID: 6608591
    [No Abstract]   [Full Text] [Related]  

  • 17. Standard photopatch testing with Waxtar, para-aminobenzoic acid, potassium dichromate and balsam of Peru.
    Kroon S
    Contact Dermatitis; 1983 Jan; 9(1):5-9. PubMed ID: 6601564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exanthema caused by ingestion of potassium p-aminobenzoate (POTABA-Glenwood(®) ).
    Meyer-Hoffert U; Jensen JM; Brasch J
    Contact Dermatitis; 2013 Jun; 68(6):381-2. PubMed ID: 23692041
    [No Abstract]   [Full Text] [Related]  

  • 19. Contact and photocontact allergy to glyceryl para-aminobenzoate.
    Bruze M; Gruvberger B; Thune P
    Photodermatol; 1988 Aug; 5(4):162-5. PubMed ID: 3266009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A response to concerns about sunscreens: a report from the Skin Cancer Foundation.
    Pathak MA; Robins P
    J Dermatol Surg Oncol; 1989 May; 15(5):486-7. PubMed ID: 2785544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.